NBY NOVABAY PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2024 - Warrant Reprice Transactions Novabay Pharmaceuticals, Inc. entered into letter agreements with existing holders of its warrants to purchase common stock, resulting in a reduced exercise price and gross proceeds of approximately $225,952.Get access to all SEC 8-K filings of the NOVABAY PHARMACEUTICALS INC